EXPD
35
3
XYL
49
2
JCI
57
7
HUM
37
-2
UNM
54
2
FDX
51
4
LEN
17
-6
LRCX
62
-3
ADI
57
-3
FITB
59
3
PCAR
23
-4
HBAN
64
4
HPE
35
2
KO
39
-13
WBA
35
-3
AON
49
2
DE
56
-2
AMP
46
3
UPS
40
12
SIG
44
-2
EXPD
35
3
XYL
49
2
JCI
57
7
HUM
37
-2
UNM
54
2
FDX
51
4
LEN
17
-6
LRCX
62
-3
ADI
57
-3
FITB
59
3
PCAR
23
-4
HBAN
64
4
HPE
35
2
KO
39
-13
WBA
35
-3
AON
49
2
DE
56
-2
AMP
46
3
UPS
40
12
SIG
44
-2
Financhill
Back

PeptiDream 10K Form

Sell
28

PPTDF
PeptiDream

Last Price:
$11.10
Seasonality Move:
-5.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PPTDF News And Ratings

See the #1 stock for the next 7 days that we like better than PPTDF

PPTDF Financial Statistics

Sales & Book Value

Annual Sales: $308.5M
Cash Flow: $-69.4M
Price / Cash Flow: 13.5
Annual Sales: $2.82
Price / Book: 3.93

Profitability

EPS (TTM): 0.80520
Net Income (TTM): $104.5M
Gross Margin: $228.1M
Return on Equity: 34.1%
Return on Assets: 20.65%

PeptiDream Earnings Forecast

Key PeptiDream Financial Ratios

  • The Gross Profit Margin over the past 13 years for PPTDF is 73.92%.
  • The Selling, General & Administrative Expenses for PPTDF have been equal to 19.52% of Gross Profit Margin.
  • The Research & Development expenses have been 8.58% of Revenue.
  • The Interest Expense is 4.39% of Operating Income.
  • The Net Earning history of PPTDF is 32.17% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 8 years.

PeptiDream Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: PPTDF
Website: peptidream.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 5.11
Quick Ratio: 4.62

Price-to-Earnings

Trailing P/E Ratio: 14.52
Forward P/E Ratio: 0

PPTDF Technical Analysis vs Fundamental Analysis

Sell
28
PeptiDream (PPTDF) is a Sell

Is PeptiDream a Buy or a Sell?

  • PeptiDream stock is rated a Sell
    The current PeptiDream [PPTDF] share price is $11.10. The Score for PPTDF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.